[1]
Ferkolj, I., Ihan, A., Markovic, S., Veceric, Z. and Pohar, M. 2006. Infliximab Reduces the Number of Activated Mucosal Lymphocytes in Patients with Crohn’s Disease. Journal of Gastrointestinal and Liver Diseases. 15, 3 (Sep. 2006), 231–235.